HealthReveal Overview
- Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
30
- Latest Deal Type
-
M&A
HealthReveal General Information
Description
Developer of a clinical analytics platform designed to preempt the avoidable consequences of chronic disease through clinically optimal care interventions. The company's analytics, machine learning, and biomonitoring technology continually monitor and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational, and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients, enabling physicians in the detection and treatment of chronic ailments at an early stage which helps patients recover faster and save healthcare costs.
Contact Information
Website
www.healthreveal.com
Formerly Known As
2015 Holdco
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Outcome Management (Healthcare)
Acquirer
Primary Office
- 326 East 65th Street
- Suite 339
- New York, NY 10022
- United States
HealthReveal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 30-Sep-2021 | 000.00 | Completed | Generating Revenue | ||
| 3. Secondary Transaction - Private | 000.00 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 23-Dec-2019 | $26.6M | $26.6M | 000.00 | Completed | Generating Revenue |
| 1. Angel (individual) | 01-Mar-2015 | $1.01K | $1.01K | Completed | Generating Revenue |
HealthReveal Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
HealthReveal Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a clinical analytics platform designed to preempt the avoidable consequences of chronic disease through cli
Decision/Risk Analysis
New York, NY
30
As of 2021
000.00
000000&0
000.00
000000
dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000000000000 000000
Harrisburg, PA
000
As of 0000
0000 0
ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
0000000 0000000000 (
Amsterdam, Netherlands
00
As of 0000
00.000
00000000000
00.000
Add Comparison
HealthReveal Competitors (39)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Geneia | Corporation | Harrisburg, PA | 000 | |||
| 0000 000000 | Venture Capital-Backed | Amsterdam, Netherlands | 00 | 00.000 | 00000000000 | 00.000 |
| 00000 | Venture Capital-Backed | Vancouver, Canada | 00 | 00.000 | 00000000000 | 00.000 |
| 000000000 | Private Equity-Backed | Boston, MA | 000 | 000.00 | 000000000000 | 000.00 |
| 0000 000000000000 | Formerly VC-backed | Boston, MA | 00 | 00000 | 0000000000. |
HealthReveal Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
HealthReveal Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Flare Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| General Electric Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Greycroft | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Manatt Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Northwell Holdings | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |